{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:52:26Z","timestamp":1792709546350,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:00:00Z","timestamp":1605312000000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jbspin.2019.01.003","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T13:45:40Z","timestamp":1547732740000},"page":"691-698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Systemic calprotectin and chronic inflammatory rheumatic diseases"],"prefix":"10.1016","volume":"86","author":[{"given":"Xavier","family":"Romand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Bernardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh Vu Chuong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Courtier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Trocme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Clapasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Paclet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athan","family":"Baillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2019.01.003_bib0005","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1016\/S0021-9258(20)89506-4","article-title":"Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells","volume":"266","author":"Edgeworth","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/330080a0","article-title":"Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis","volume":"330","author":"Odink","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0015","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jmb.2007.04.065","article-title":"The crystal structure of the human (S100A8\/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins","volume":"370","author":"Kornd\u00f6rfer","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0020","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1089\/ars.2010.3641","article-title":"Oxidative modifications of DAMPs suppress inflammation: the case for S100A8 and S100A9","volume":"15","author":"Lim","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/rheumatology\/ket375","article-title":"TLR4 endogenous ligand MRP8\/14 level in enthesitis-related arthritis and its association with disease activity and TLR4 expression","volume":"53","author":"Rahman","year":"2014","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/rheumatology\/kep452","article-title":"Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases","volume":"49","author":"Baillet","year":"2010","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0035","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X","article-title":"Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis","volume":"43","author":"Frosch","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0040","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard.2006.064741","article-title":"Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis","volume":"66","author":"Hammer","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0045","first-page":"880","article-title":"Elevated serum levels of calprotectin (myeloid-related protein 8\/14) in patients with ankylosing spondylitis and its association with disease activity and quality of life","volume":"62","author":"Oktayoglu","year":"2014","journal-title":"J Investig Med Off Publ Am Fed Clin Res"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.autrev.2013.11.003","article-title":"Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients","volume":"13","author":"Thai","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1258\/acb.2012.011272","article-title":"Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits","volume":"50","author":"Whitehead","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0060","doi-asserted-by":"crossref","first-page":"40277","DOI":"10.1371\/journal.pone.0040277","article-title":"Molecular interface of S100A8 with cytochrome b558 and NADPH oxidase activation","volume":"7","author":"Berthier","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0065","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.molimm.2011.07.006","article-title":"Neutrophils and T cells: bidirectional effects and functional interferences","volume":"48","author":"Thewissen","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/emm.2013.39","article-title":"MRP8 promotes Th17 differentiation via upregulation of IL-6 production by fibroblast-like synoviocytes in rheumatoid arthritis","volume":"45","author":"Lee","year":"2013","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0075","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbrc.2012.05.162","article-title":"S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin","volume":"423","author":"Lee","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0080","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/art.10988","article-title":"Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis","volume":"48","author":"Kane","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0085","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3899\/jrheum.140628","article-title":"Calprotectin as a biomarker for rheumatoid arthritis: a systematic review","volume":"42","author":"Abildtrup","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0090","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/ar3503","article-title":"The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab","volume":"13","author":"Hammer","year":"2011","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.jbspin.2019.01.003_bib0095","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/ard.2008.103739","article-title":"Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis","volume":"69","author":"Hammer","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0100","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1136\/annrheumdis-2017-211695","article-title":"Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis","volume":"76","author":"Jonsson","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.jbspin.2019.01.003_bib0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/annrheumdis-2017-212816","article-title":"Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis. Comment on \u00ab Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis \u00bb by Jonsson et al.","volume":"77","author":"Chevreau","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0110","doi-asserted-by":"crossref","first-page":"e0183420","DOI":"10.1371\/journal.pone.0183420","article-title":"Relationship between serum calprotectin (S100A8\/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: a large cohort study","volume":"12","author":"Hurnakova","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13075-016-1201-0","article-title":"Calprotectin (S100A8\/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis","volume":"19","author":"Nordal","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13075-016-1032-z","article-title":"Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity","volume":"18","author":"Inciarte-Mundo","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0125","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3899\/jrheum.150998","article-title":"Myeloid-related protein 8\/14 Levels in rheumatoid arthritis: marker of disease activity and response to methotrexate","volume":"43","author":"Patro","year":"2016","journal-title":"J Rheumatol."},{"key":"10.1016\/j.jbspin.2019.01.003_bib0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1371\/journal.pone.0115800","article-title":"Identification of S100A9 as biomarker of responsiveness to the methotrexate\/etanercept combination in rheumatoid arthritis using a proteomic approach","volume":"9","author":"Obry","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2013-203923","article-title":"MRP8\/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis","volume":"74","author":"Choi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0140","doi-asserted-by":"crossref","first-page":"e000654","DOI":"10.1136\/rmdopen-2018-000654","article-title":"Predictive value of serum calprotectin (S100A8\/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis","volume":"4","author":"Tweehuysen","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0145","first-page":"1019","article-title":"The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohort","volume":"56","author":"Smith","year":"2017","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0155","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/art.40475","article-title":"Magnetic resonance imaging of the sacroiliac joints indicating sacroiliitis according to the assessment of spondyloarthritis international society definition in healthy individuals, runners, and women with postpartum back pain","volume":"70","author":"de Winter","year":"2018","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0160","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/art.40075","article-title":"Bone marrow edema in the sacroiliac joint-degenerative sacroiliac joint disease might be more likely than spondyloarthritis: comment on the article by Turina","volume":"69","author":"Baillet","year":"2017","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0165","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/rheumatology\/kep393","article-title":"Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs\/coxibs\u2019 treatment effect on C-reactive protein","volume":"49","author":"Benhamou","year":"2010","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0170","first-page":"59","article-title":"A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis","volume":"13","author":"Hammer","year":"1995","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.jbspin.2019.01.003_bib0175","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2015-208025","article-title":"Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis","volume":"75","author":"Cypers","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0180","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1007\/s10067-016-3448-x","article-title":"Elevated levels of serum MRP8\/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease","volume":"35","author":"Gupta","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0185","doi-asserted-by":"crossref","first-page":"7574147","DOI":"10.1155\/2017\/7574147","article-title":"Discriminating value of calprotectin in disease activity and progression of nonradiographic axial spondyloarthritis and ankylosing spondylitis","volume":"2017","author":"Huang","year":"2017","journal-title":"Dis Markers"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/00365521.2011.648953","article-title":"Calprotectin in ankylosing spondylitis--frequently elevated in feces, but normal in serum","volume":"47","author":"Klingberg","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0195","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/annrheumdis-2014-205506","article-title":"Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis","volume":"73","author":"Turina","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0200","doi-asserted-by":"crossref","first-page":"e000319","DOI":"10.1136\/rmdopen-2016-000319","article-title":"Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort","volume":"3","author":"Turina","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0205","doi-asserted-by":"crossref","DOI":"10.2174\/1573397112666160331143000","article-title":"Serum calprotectin levels as a marker of arthritis: an italian experience","author":"Grossi","year":"2016","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0210","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-Reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0215","first-page":"107","article-title":"Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization","volume":"41","author":"Fukunaga","year":"2018","journal-title":"Int J Mol Med."},{"key":"10.1016\/j.jbspin.2019.01.003_bib0220","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s13075-014-0413-4","article-title":"Calprotectin (S100A8\/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis","volume":"16","author":"Turina","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0225","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","article-title":"Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Baeten","year":"2013","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0230","first-page":"2089","article-title":"S100 proteins calprotectin and S100A12 are related to radiographic changes rather than disease activity in psoriatic arthritis with low disease activity","volume":"34","author":"Madland","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0235","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/art.11177","article-title":"Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis","volume":"48","author":"Frosch","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0240","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/rheumatology\/ket152","article-title":"A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8\/14 protein","volume":"52","author":"Moncrieffe","year":"2013","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0245","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0250","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2012-03-416156","article-title":"Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity","volume":"120","author":"Sangaletti","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0255","doi-asserted-by":"crossref","first-page":"e1000639","DOI":"10.1371\/journal.ppat.1000639","article-title":"Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans","volume":"5","author":"Urban","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0260","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1053\/j.gastro.2003.08.035","article-title":"Subclinical intestinal inflammation and sacroiliac changes in relatives of patients with ankylosing spondylitis","volume":"125","author":"Bjarnason","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0265","first-page":"S117","article-title":"ANCA against bactericidal\/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associations","volume":"21","author":"Schultz","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0270","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/ki.2013.2","article-title":"Leukocyte and serum S100A8\/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis","volume":"83","author":"Pepper","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0275","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.ajpath.2015.01.015","article-title":"S100A8\/A9 (calprotectin) is critical for development of glomerulonephritis and promotes inflammatory leukocyte-renal cell interactions","volume":"185","author":"Pepper","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0280","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/art.39814","article-title":"Association of serum calprotectin (S100A8\/A9) level with disease relapse in proteinase 3-antineutrophil cytoplasmic antibody-associated vasculitis","volume":"69","author":"Pepper","year":"2017","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0285","doi-asserted-by":"crossref","first-page":"9060","DOI":"10.1021\/bi953033d","article-title":"Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements","volume":"35","author":"Li","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0290","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/ar3426","article-title":"Decreases in serum levels of S100A8\/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis","volume":"13","author":"Andr\u00e9s Cerezo","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.01.003_bib0295","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13075-016-1180-1","article-title":"Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis","volume":"18","author":"Levitova","year":"2016","journal-title":"Arthritis Res Ther"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18303403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18303403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:25:46Z","timestamp":1761150346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X18303403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1297319X18303403"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.01.003","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic calprotectin and chronic inflammatory rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}